Max Robotics — Global Service Robot Directory + US Certification

About

Francisco Civantos is a leading head and neck surgeon whose work has fundamentally shaped the management of oropharyngeal cancer, particularly in the era of human papillomavirus (HPV). His key research focuses on transoral robotic surgery (TORS) and the evolving treatment of squamous cell carcinoma, including cases of unknown primary origin. Civantos has been instrumental in demonstrating the efficacy of TORS as a minimally invasive alternative to traditional chemoradiation, helping to reduce morbidity while maintaining excellent oncologic outcomes. His highly cited 2017 study (61 citations) critically evaluated survival outcomes by treatment strategy for HPV-related oropharyngeal cancer, providing pivotal evidence for surgical decision-making. He also authored a comprehensive 2020 review (42 citations) on managing cervical lymph node metastases from unknown primaries, offering a modern framework for diagnosis and treatment in the HPV era. Additionally, his 2019 meta-analysis (32 citations) compared transoral surgical modalities, guiding surgeons toward optimal approaches. Civantos’s work has not only advanced surgical techniques but also clarified the role of HPV in prognosis and treatment de-escalation, making him a key figure in contemporary head and neck oncology.